Literature DB >> 17287693

Extralobar pulmonary sequestration showing high CA 19-19 levels.

D Fontana1, V Della Beffa, M Fusca, F Loddo.   

Abstract

We report a case of 40 year-old woman with left thoracic pain who was diagnosed as having a cystic mass located posteriorly at the basis of the left pleural cavity. The preoperative serum CA 19-9 level was increased (2 900 IU/mL). Further investigations did not find neoplastic lesions in the gastrointestinal tract. The intraoperative finding of an anomalous systemic arterial supply to the mass suggested the diagnosis of extralobar sequestration, confirmed at the histopathological examination. The association between pulmonary sequestration and increased tumor markers levels is overlooked in western literature, but it is often reported by many Japanese authors. This case report would underline the practical usefulness for preoperative diagnosis of pulmonary sequestration, when the CT-scan does not demonstrated an anomalous systemic vessel. The common embryogenic origin of both respiratory and digestive apparatus can explain the increased levels of tumor markers such as CA 19-9 and carcinoembryonic antigen in bronchogenic cyst, intestinal duplication and pulmonary sequestration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287693

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  3 in total

1.  Pulmonary sequestration associated with a synchronous elevation of carbohydrate antigen 50 and 19-9: a case report.

Authors:  Shaozi Fu; Haitao Wang
Journal:  Ann Transl Med       Date:  2018-06

2.  Intralobar pulmonary sequestration with aspergillus infection and elevated serum CA19-9 and CA242: a case report.

Authors:  Li Ge; Shan Wang; Hongrui Liu; Xiaohua Shi; Juhong Shi; Ruie Feng
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

Review 3.  Extralobar pulmonary sequestration with elevated serum neuron-specific enolase: A case report and review of the literature.

Authors:  Feng-Wei Kong; Wei-Min Wang; Longbo Gong; Wenbin Wu; Miao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.